-
2
-
-
0034657667
-
® 974P mixtures for the nasal delivery of insulin in rabbits
-
® 974P mixtures for the nasal delivery of insulin in rabbits. J. Control. Release 66 (2000) 215-220
-
(2000)
J. Control. Release
, vol.66
, pp. 215-220
-
-
Callens, C.1
Remon, J.P.2
-
3
-
-
0021718724
-
Intranasal drug administration for systemic medication
-
Chang S.F., and Chien Y.W. Intranasal drug administration for systemic medication. Pharm. Int. 5 (1984) 287-288
-
(1984)
Pharm. Int.
, vol.5
, pp. 287-288
-
-
Chang, S.F.1
Chien, Y.W.2
-
4
-
-
0003959411
-
Historical developments of transnasal systemic medications
-
Chien Y.W. (Ed), Elsevier, Amsterdam, The Netherlands
-
Chien Y.W., and Chang Y. Historical developments of transnasal systemic medications. In: Chien Y.W. (Ed). Transnasal Systemic Medications: Fundamentals, Developmental Concepts and Biomedical Assessments (1985), Elsevier, Amsterdam, The Netherlands 1-100
-
(1985)
Transnasal Systemic Medications: Fundamentals, Developmental Concepts and Biomedical Assessments
, pp. 1-100
-
-
Chien, Y.W.1
Chang, Y.2
-
5
-
-
58749113606
-
Spray-dried powders of starch and crosslinked poly(acrylic acid) as carriers for nasal delivery of inactivated influenza vaccine
-
Coucke D., Schotsaert M., Libert C., Pringels E., Vervaet C., Foreman P., Saelens X., and Remon J.P. Spray-dried powders of starch and crosslinked poly(acrylic acid) as carriers for nasal delivery of inactivated influenza vaccine. Vaccine 27 (2009) 1279-1286
-
(2009)
Vaccine
, vol.27
, pp. 1279-1286
-
-
Coucke, D.1
Schotsaert, M.2
Libert, C.3
Pringels, E.4
Vervaet, C.5
Foreman, P.6
Saelens, X.7
Remon, J.P.8
-
6
-
-
67650635119
-
-
® 974P used as carriers for nasal drug delivery, Int. J. Pharm., doi:10.1016/j.ijpharm.2009.05.041.
-
® 974P used as carriers for nasal drug delivery, Int. J. Pharm., doi:10.1016/j.ijpharm.2009.05.041.
-
-
-
-
7
-
-
0036076115
-
β-Adrenergic blockers in systemic hypertension. pharmacokinetic considerations related to the current guidelines
-
Frishman W.H., and Alwarshetty M. β-Adrenergic blockers in systemic hypertension. pharmacokinetic considerations related to the current guidelines. Clin. Pharmacokin. 41 (2002) 505-516
-
(2002)
Clin. Pharmacokin.
, vol.41
, pp. 505-516
-
-
Frishman, W.H.1
Alwarshetty, M.2
-
8
-
-
33645018003
-
Formulation of a dry powder influenza vaccine for nasal delivery
-
Garmise R.J., Mar K., Crowder T.M., Hwang C.R., Ferriter M., Huang J., Mikszta J.A., Sullivan V.J., and Hickey A.J. Formulation of a dry powder influenza vaccine for nasal delivery. AAPS Pharm. Sci. Tech. 7 (2006) 19
-
(2006)
AAPS Pharm. Sci. Tech.
, vol.7
, pp. 19
-
-
Garmise, R.J.1
Mar, K.2
Crowder, T.M.3
Hwang, C.R.4
Ferriter, M.5
Huang, J.6
Mikszta, J.A.7
Sullivan, V.J.8
Hickey, A.J.9
-
9
-
-
41549113408
-
Coprocessing via spray drying as a formulation platform to improve the compactibility of various drugs
-
Gonnissen Y., Verhoeven E., Peeters E., Remon J.P., and Vervaet C. Coprocessing via spray drying as a formulation platform to improve the compactibility of various drugs. Eur. J. Pharm. Biopharm. 69 (2008) 320-334
-
(2008)
Eur. J. Pharm. Biopharm.
, vol.69
, pp. 320-334
-
-
Gonnissen, Y.1
Verhoeven, E.2
Peeters, E.3
Remon, J.P.4
Vervaet, C.5
-
10
-
-
0032969698
-
Intranasal insulin delivery and therapy
-
Hinchcliffe M., and Illum L. Intranasal insulin delivery and therapy. Adv. Drug Del. Rev. 35 (1999) 199-234
-
(1999)
Adv. Drug Del. Rev.
, vol.35
, pp. 199-234
-
-
Hinchcliffe, M.1
Illum, L.2
-
12
-
-
0344541952
-
The effect of a viscosity and an absorption enhancer on the intra nasal absorption of metoprolol in rats
-
Kilian N., and Müller D.G. The effect of a viscosity and an absorption enhancer on the intra nasal absorption of metoprolol in rats. Int. J. Pharm. 163 (1998) 211-217
-
(1998)
Int. J. Pharm.
, vol.163
, pp. 211-217
-
-
Kilian, N.1
Müller, D.G.2
-
14
-
-
0037273252
-
Sodium alginate microspheres of metoprolol tartrate for intranasal systemic delivery: development and evaluation
-
Rajinikanth P.S., Sankar C., and Mishra B. Sodium alginate microspheres of metoprolol tartrate for intranasal systemic delivery: development and evaluation. Drug Del. 1 (2003) 21-28
-
(2003)
Drug Del.
, vol.1
, pp. 21-28
-
-
Rajinikanth, P.S.1
Sankar, C.2
Mishra, B.3
-
15
-
-
0343132747
-
Animal models for buccal and nasal delivery studies
-
Duchêne, D, Ed, December, Editions de Santé, pp
-
Sørensen, A., 1991. Animal models for buccal and nasal delivery studies, in: Duchêne, D. (Ed.), Buccal and Nasal Administration as an Alternative to Parenteral Administration, European Symposium, Paris, 10-11 December, Editions de Santé, pp. 162-173.
-
(1991)
Buccal and Nasal Administration as an Alternative to Parenteral Administration, European Symposium, Paris, 10-11
, pp. 162-173
-
-
Sørensen, A.1
-
16
-
-
0037148674
-
Nasal glucagon delivery using microcrystalline cellulose in healthy volunteers
-
Teshima D., Yamauchi A., Makino K., Kataoka Y., Arita Y., Nawata H., and Oishi R. Nasal glucagon delivery using microcrystalline cellulose in healthy volunteers. Int. J. Pharm. 233 (2002) 61-66
-
(2002)
Int. J. Pharm.
, vol.233
, pp. 61-66
-
-
Teshima, D.1
Yamauchi, A.2
Makino, K.3
Kataoka, Y.4
Arita, Y.5
Nawata, H.6
Oishi, R.7
-
17
-
-
26644434124
-
Nasal mucoadhesive drug delivery: background, applications, trends and future perspectives
-
Ugwoke M.I., Agu R.U., Verbeke N., and Kinget R. Nasal mucoadhesive drug delivery: background, applications, trends and future perspectives. Adv. Drug Del. Rev. 57 (2005) 1640-1665
-
(2005)
Adv. Drug Del. Rev.
, vol.57
, pp. 1640-1665
-
-
Ugwoke, M.I.1
Agu, R.U.2
Verbeke, N.3
Kinget, R.4
|